| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 110 |
| 1 | TADALAFIL | 42 |
| 2 | SILDENAFIL CITRATE | 33 |
| 3 | AMBRISENTAN | 31 |
| 4 | WARFARIN | 16 |
| 5 | MACITENTAN | 15 |
| 6 | SILDENAFIL | 13 |
| 7 | BOSENTAN | 11 |
| 8 | ACETAMINOPHEN | 8 |
| 9 | SILDENAFIL POWDER, | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARSENICUM ALBUM, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM, IODIUM, LYCOPODIUM, PULSATILLA | 1 | 0.0145 |
| 1 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 2 | OXYMETAZOLINE HCL | 1 | 0.0018 |
| 3 | TREPROSTINIL | 110 | 0.0009 |
| 4 | SAFINAMIDE MESYLATE | 1 | 0.0007 |
| 5 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 6 | MIDODRINE HYDROCHLORIDE | 3 | 0.0007 |
| 7 | PLECANATIDE | 1 | 0.0005 |
| 8 | PRUCALOPRIDE | 1 | 0.0004 |
| 9 | TADALAFIL | 42 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 111 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 50 |
| 2 | Endothelin Receptor Antagonist [EPC] | 46 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 4 | Amide Local Anesthetic [EPC] | 8 |
| 5 | Antiarrhythmic [EPC] | 8 |
| 6 | Loop Diuretic [EPC] | 7 |
| 7 | Osmotic Laxative [EPC] | 7 |
| 8 | Benzodiazepine [EPC] | 5 |
| 9 | Human Immunoglobulin G [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 111 | 0.0008 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 50 | 0.0004 |
| 3 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 4 | Endothelin Receptor Antagonist [EPC] | 46 | 0.0002 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |
| 8 | Amide Local Anesthetic [EPC] | 8 | 0.0001 |
| 9 | Antiarrhythmic [EPC] | 8 | 0.0001 |